Not only is Arranta blazing a trail in designing technology essential to LBP development, we're also also taking a lead on addressing gaps in regulatory guidance. In our upcoming white paper, we'll be providing information on regulatory considerations for LBPs.
Fill out the short form below to be one of the first to receive the white paper upon publication.
We're always open to engaging with individuals interested in our company or the microbiome therapy market in general.
We look forward to hearing from you.